Adhera Therapeutics, Inc. (ATRX)
OTCMKTS: ATRX · Delayed Price · USD
0.0084
+0.0003 (3.70%)
Jul 18, 2024, 4:00 PM EDT - Market closed
Adhera Therapeutics Market Cap
Adhera Therapeutics has a market cap or net worth of $60.66 thousand as of July 22, 2024. Its market cap has decreased by -95.67% in one year.
Market Cap
60.66K
Enterprise Value
10.86M
1-Year Change
-95.67%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since December 1, 1998, Adhera Therapeutics's market cap has decreased from $23.90M to $60.66K, a decrease of -99.75%. That is a compound annual growth rate of -22.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 8, 2022 | 1.10M | -8.33% |
Dec 31, 2021 | 1.20M | 200.00% |
Dec 31, 2020 | 400.00K | -42.86% |
Dec 31, 2019 | 700.00K | -76.67% |
Dec 31, 2018 | 3.00M | -82.76% |
Dec 29, 2017 | 17.40M | 28.89% |
Dec 30, 2016 | 13.50M | 87.50% |
Dec 31, 2015 | 7.20M | -57.40% |
Dec 31, 2014 | 16.90M | 160.00% |
Dec 31, 2013 | 6.50M | -7.14% |
Dec 31, 2012 | 7.00M | -13.58% |
Dec 30, 2011 | 8.10M | -79.44% |
Dec 31, 2010 | 39.40M | 19.03% |
Dec 31, 2009 | 33.10M | 212.26% |
Dec 31, 2008 | 10.60M | -89.19% |
Dec 31, 2007 | 98.10M | -70.53% |
Dec 29, 2006 | 332.90M | 9.51% |
Dec 30, 2005 | 304.00M | 86.50% |
Dec 31, 2004 | 163.00M | 43.36% |
Dec 31, 2003 | 113.70M | 30.54% |
Dec 31, 2002 | 87.10M | -30.21% |
Dec 31, 2001 | 124.80M | 162.18% |
Dec 29, 2000 | 47.60M | 124.53% |
Dec 31, 1999 | 21.20M | -14.17% |
Dec 31, 1998 | 24.70M | 3.35% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 814.94B |
Novo Nordisk | 579.91B |
UnitedHealth Group | 520.32B |
Johnson & Johnson | 372.29B |
Merck & Co. | 318.55B |
AbbVie | 304.29B |
AstraZeneca | 244.04B |
Novartis AG | 207.64B |